We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

111 hedge funds and large institutions have $266M invested in GenMark Diagnostics, Inc in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 49 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 28

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

1% more funds holding

Funds holding: 110 → 111 (+1)

17% less capital invested

Capital invested by funds: $320M → $266M (-$53.9M)

Holders
111
Holders Change
+1
Holders Change %
+0.91%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
49
Reduced
28
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.79M
2
NIM
Needham Investment Management
New York
+$3.01M
3
Bank of America
Bank of America
North Carolina
+$2.35M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.04M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.89M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$2.49M
3
Millennium Management
Millennium Management
New York
-$1.86M
4
MAG
Millrace Asset Group
Pennsylvania
-$1.6M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
76
Royce & Associates
New York
$150K – – –
CS
77
Credit Suisse
Switzerland
$141K -$68.2K -12,363 -30%
VOYA Investment Management
78
VOYA Investment Management
Georgia
$138K +$34.9K +6,327 +28%
AGM
79
Alpine Global Management
New York
$133K +$152K +27,615 New
State Board of Administration of Florida Retirement System
80
State Board of Administration of Florida Retirement System
Florida
$128K – – –
MIM
81
MetLife Investment Management
New Jersey
$127K – – –
Stifel Financial
82
Stifel Financial
Missouri
$126K +$23.3K +4,224 +20%
SI
83
Stephens Inc
Arkansas
$99K -$16.6K -3,008 -13%
Legal & General Group
84
Legal & General Group
United Kingdom
$96K +$12.3K +2,237 +13%
MLICM
85
Metropolitan Life Insurance Company (MetLife)
New York
$89.8K -$1.55K -281 -1%
ARTA
86
A.R.T. Advisors
New York
$79K -$23.2K -4,200 -20%
PPA
87
Parametric Portfolio Associates
Washington
$75K +$10.1K +1,825 +13%
Citigroup
88
Citigroup
New York
$64K +$33.6K +6,094 +84%
GF
89
Gabelli Funds
New York
$50K – – –
AB
90
Amalgamated Bank
New York
$50K +$57.7K +10,457 New
Bank of Montreal
91
Bank of Montreal
Ontario, Canada
$49K +$12.9K +2,333 +30%
BNP Paribas Financial Markets
92
BNP Paribas Financial Markets
France
$38K -$2.77K -503 -6%
TWA
93
TCI Wealth Advisors
Arizona
$33K – – –
AG
94
Advisor Group
Arizona
$21K +$7.18K +1,302 +44%
AIP
95
Ameritas Investment Partners
Nebraska
$18K – – –
AIM
96
Aigen Investment Management
New York
$18K +$20.6K +3,726 New
Canada Life
97
Canada Life
Manitoba, Canada
$18K +$21.4K +3,881 New
IF
98
Ironwood Financial
Arizona
$17K – – –
Zurich Cantonal Bank
99
Zurich Cantonal Bank
Switzerland
$17K – – –
First Manhattan
100
First Manhattan
New York
$9K – – –
1 2 3
4
5

GNMK Hedge Fund Activity: Q4 2019 in Review

111 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2019, worth a combined $266M — down 17% from $320M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GNMK positions and 9 closed out — a net gain of 1 holder — while 49 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.79M. The largest seller was T. Rowe Price Associates, cutting an estimated $4.89M.

  • 111 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2019, up from 110 in Q3 2019.
  • Funds reported $266M of GenMark Diagnostics, Inc stock for Q4 2019, down 17% quarter-over-quarter.
  • 10 funds opened new GenMark Diagnostics, Inc positions in Q4 2019 and 9 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2019 was Morgan Stanley, an estimated $5.79M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2019 was T. Rowe Price Associates, an estimated $4.89M sold.

Based on aggregated 13F filings for Q4 2019.